D2/D3 dopamine receptor heterodimers exhibit unique functional properties

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Recent evidence suggests heterodimerization among G protein-coupled receptors, including dopamine and adenosine receptors.
• The functional interaction between dopamine D(2) and D(3) receptors, specifically through heterodimerization, remains largely unexplored.

Purpose of the Study:

• To investigate the potential functional interaction and heterodimerization between dopamine D(2) and D(3) receptors.
• To characterize the pharmacological profiles of split receptor fragments and their influence on adenylyl cyclase activity.

Main Methods:

• Construction and co-transfection of split dopamine D(2) and D(3) receptor fragments (trunk and tail domains).
• Pharmacological characterization of native and split receptor fragments using agonists and antagonists.
• Assessment of adenylyl cyclase V and VI inhibition by native and split receptors, and co-immunoprecipitation assays.

Main Results:

• Pharmacological profiles of heterologous split receptor fragments (D(3trunk)/D(2tail)) differed from native receptors, with D(3trunk)/D(2tail) showing high affinity.
• Split receptor fragments reduced wild-type D(2) and D(3) receptor expression, suggesting complex formation and impaired membrane targeting.
• Dopamine D(2) and D(3) receptors functionally interact to inhibit adenylyl cyclase VI, with co-expression significantly enhancing inhibition potency.

Conclusions:

• Dopamine D(2) and D(3) receptors are capable of physical interaction and heterodimerization.
• Heterodimerization influences receptor pharmacology and functional coupling to adenylyl cyclase.
• This interaction provides a novel regulatory mechanism for dopamine receptor signaling.